JFLLIFE — JFL Life Sciences Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapTurnaround

Annual income statement for JFL Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	336	428	465	820	1,314
Cost of Revenue
Gross Profit	77.9	81.8	76.9	159	164
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	286	393	424	748	1,207
Operating Profit	49.9	35	41	72.1	106
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	38	37.2	38	61.4	86
Provision for Income Taxes
Net Income After Taxes	28.1	28.1	33.1	41.6	64
Net Income Before Extraordinary Items
Net Income	28.1	28.1	33.1	41.6	64
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	28.1	28.1	33.1	41.6	64
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.47	0.922	0.957	1.2	1.94
Dividends per Share